ID   ROT68/C1 Cis-Ptr
AC   CVCL_HA31
SY   Cis-Ptr
DR   Wikidata; Q54950840
RX   PubMed=2702997;
RX   PubMed=3169090;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C129858; Rat ovarian adenocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HA30 ! ROT68/C1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 13
//
RX   PubMed=2702997; DOI=10.1016/0277-5379(89)90255-1;
RA   Sekiya, Souei
RA   Oosaki, Tatsuya
RA   Andoh, S.
RA   Suzuki, N.
RA   Akaboshi, Mitsuhiko
RA   Takamizawa, Hiroyoshi
RT   "Mechanisms of resistance to cis-diamminedichloroplatinum (II) in a
RT   rat ovarian carcinoma cell line.";
RL   Eur. J. Cancer Clin. Oncol. 25:429-437(1989).
//
RX   PubMed=3169090; DOI=10.1016/0277-5379(88)90193-9;
RA   Sekiya, Souei
RA   Oosaki, Tatsuya
RA   Andoh, S.
RA   Suzuki, N.
RA   Nagao, Koichi
RA   Takamizawa, Hiroyoshi
RT   "The isolation and characterization of cisplatin-resistant rat ovarian
RT   cancer cells.";
RL   Eur. J. Cancer Clin. Oncol. 24:851-859(1988).
//